SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-22-000006
Filing Date
2022-08-12
Accepted
2022-08-12 16:04:47
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlk-20220630.htm   iXBRL 10-Q 1453853
2 EX-31.1 mltx_2022q2xex311dasilva.htm EX-31.1 10402
3 EX-31.2 mltx_2022q2xex312bodenstedt.htm EX-31.2 10314
4 EX-32.1 mltx_2022q2xex321dasilva.htm EX-32.1 5041
5 EX-32.2 mltx_2022q2xex322bodenstedt.htm EX-32.2 4978
  Complete submission text file 0001821586-22-000006.txt   6866256

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20220630.xsd EX-101.SCH 44265
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlk-20220630_cal.xml EX-101.CAL 59523
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlk-20220630_def.xml EX-101.DEF 281606
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20220630_lab.xml EX-101.LAB 488071
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20220630_pre.xml EX-101.PRE 390924
61 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20220630_htm.xml XML 1138764
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 221159967
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences